ONCOLOGY Vol 36, Issue 5 | Oncology

Expert Commentary On The Product Profile Of Dostarlimab

May 10, 2022


In an interview with ONCOLOGY®, Megan May, PharmD, BCOP, offers a comprehensive review of real-world treatment considerations of dostarlimab as therapy for adult patients with recurrent or advanced solid tumors with deficient mismatch repair.